PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Abstract Protein kinase C substrate 80K-H (PRKCSH) plays a crucial role in the protein N-terminal glycosylation process, with emerging evidence implicating its involvement in tumorigenesis. To comprehensively assess PRKCSH’s significance across cancers, we conducted a pan-cancer analysis using data...
Main Authors: | Qiankun Wang, Xiong Wang, Jiaoyuan Li, Tongxin Yin, Yi Wang, Liming Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-52153-w |
Similar Items
-
TFDP1 is a potential diagnostic, immunological and prognostic biomarker in pan-cancer
by: Yipeng Zhang, et al.
Published: (2024-05-01) -
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
by: Xiong Liu, et al.
Published: (2024-01-01) -
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
by: Guoming Chen, et al.
Published: (2022-03-01) -
Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker
by: Tiantian Wang, et al.
Published: (2024-03-01) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
by: Hua Zhu, et al.
Published: (2021-09-01)